Contact

Wide Anchor 69 Home About Services Safety & Risks Quality & Contents Legal & Clinical Context Contact Evidence-first safety briefing Ibogaine Capsules: What They Are And The Risks Capsules can make a powerful psychoactive substance look simple. They are not a conventional supplement, and the format does not resolve uncertainty about dose, purity, legal status, or serious medical risk. The central concern is cardiac risk: ibogaine may alter cardiac electrical activity and can be dangerous without careful screening, monitoring, and emergency capability. Not routine care Ibogaine is not FDA-approved for addiction treatment in the United States. Cardiac screening matters QT prolongation can precede dangerous rhythm disturbances and cardiac arrest. Capsule ≠ quality Product contents and dose may be uncertain outside controlled research settings. 01 / origin & format Understanding a plant-derived psychoactive substance Ibogaine is a naturally occurring psychoactive alkaloid derived from the root bark of the Tabernanthe iboga plant, native to Central and West Africa. The WebMD overview of iboga describes why this plant-derived compound is treated differently from ordinary dietary products. For centuries, indigenous communities in Gabon and Cameroon have used iboga in spiritual and healing rituals, often facilitated by Bwiti shamans. It is classified as a psychedelic drug because profound psychoactive effects can include vivid visions and introspective experiences; the botanical history of Tabernanthe iboga gives useful context for that origin. The natural plant contains multiple alkaloids, with ibogaine the most studied for possible anti-addictive properties. A capsule may contain purified hydrochloride, ground root bark, an extract, or a product whose contents do not match the label. Capsule describes a delivery format, not a pharmaceutical standard. That uncertainty matters for drug addiction and addiction treatment. Products may vary in dose and purity,

Contact

Published channels